Cargando…

Association of emergence of new mutations in circulating tumuor DNA during chemotherapy with clinical outcome in metastatic colorectal cancer

BACKGROUND: The understanding of molecular changes in mCRC during treatment could be used to personalise therapeutic strategies. The aim of our study was to explore the association of circulating tumour DNA (ctDNA) with clinical outcome in metastatic colorectal cancer (mCRC). METHODS: Sequential pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Ning, Chang, Lianpeng, Gao, Xin, Shi, Xiaohua, Dou, Xuelin, Guan, Mei, Shao, Yajuan, Li, Ningning, Cheng, Yuejuan, Ying, Hongyan, Sun, Zhao, Zhou, Yanping, Zhao, Lin, Zhou, Jianfeng, Bai, Chunmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296534/ https://www.ncbi.nlm.nih.gov/pubmed/34294055 http://dx.doi.org/10.1186/s12885-021-08309-2

Ejemplares similares

Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response
por: Jia, Ning, et al.
Publicado: (2019)

GASTROINTESTINAL STROMAL TUMUOR- CASE REPORT AND A REVIEW OF THE LITERATURE
por: Akere, A, et al.
Publicado: (2008)

Systemic treatment of a metastatic carotid body tumor: A case report and literature review
por: Xing, Jiazhang, et al.
Publicado: (2020)

Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy
por: Li, Ningning, et al.
Publicado: (2023)

Adjuvant Chemotherapy with Docetaxel, Cisplatin, and Continuous-Infusion 5-Fluorouracil for Gastric Cancer: A Phase II Study()
por: Meng, Changting, et al.
Publicado: (2014)

Clinical features and prognosis of lung cancer in patients with connective tissue diseases: a retrospective cohort study
por: Li, Ningning, et al.
Publicado: (2023)

QOL-25. MICROSTRUCTURAL BRAIN CHANGES ASSOCIATED WITH NEUROCOGNITIVE AND FUNCTIONAL OUTCOMES OF INTRACRANIAL GERM CELL TUMUOR SURVIVORS – A DIFFUSIONAL KURTOSIS IMAGING STUDY
por: Tso, Wan-Yee Winnie, et al.
Publicado: (2020)

Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection
por: Xing, Jiazhang, et al.
Publicado: (2021)

The Relationship Between Gut Microbiome Features and Chemotherapy Response in Gastrointestinal Cancer
por: Li, Ningning, et al.
Publicado: (2021)

A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma
por: Tang, Hui, et al.
Publicado: (2023)

Immune Checkpoint Markers in Neuroendocrine Carcinoma of the Digestive System
por: Xing, Jiazhang, et al.
Publicado: (2020)

Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer
por: Zhou, Jiaolin, et al.
Publicado: (2016)

Increased Stromal Infiltrating Lymphocytes are Associated with Circulating Tumor Cells and Metastatic Relapse in Breast Cancer Patients After Neoadjuvant Chemotherapy
por: Liu, Jiawei, et al.
Publicado: (2019)

Pharmacokinetics, Safety, and Preliminary Efficacy of Oral Trifluridine/Tipiracil in Chinese Patients with Solid Tumors: A Phase 1b, Open-Label Study
por: Wang, Xicheng, et al.
Publicado: (2020)

HBV Infection Status Does Not Influence the Initial Metastatic Pattern and the Prognosis of Breast Cancer Patients with de novo and Relapsed Metastatic Disease
por: Zhang, Ningning, et al.
Publicado: (2022)

Evolving landscape of clinical trials in gastroenteropancreatic neuroendocrine neoplasms in the past two decades
por: Yang, Kaili, et al.
Publicado: (2023)

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma
por: Zhou, Han, et al.
Publicado: (2020)

Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System
por: Bai, Yongrui, et al.
Publicado: (2017)

T-cell lymphoma with abundant CD20 expression showing a good response to rituximab with gemcitabine, oxiplatin, and L-asparaginase (R-pGEMOX): A case report
por: Shao, Yajuan, et al.
Publicado: (2018)

Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic ductal adenocarcinoma
por: Zhu, Zhou, et al.
Publicado: (2023)

Development of long-circulating lapachol nanoparticles: formation, characterization, pharmacokinetics, distribution and cytotoxicity
por: Chen, Qunying, et al.
Publicado: (2020)

Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer
por: Galsky, Matthew D, et al.
Publicado: (2015)

Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance
por: Hu, Zhe-Yu, et al.
Publicado: (2018)

Identification of circulating tumor DNA using a targeted 545-gene next generation sequencing panel in patients with gastric cancer
por: Lan, Jing, et al.
Publicado: (2020)

Long-Circulation and Brain Targeted Isoliquiritigenin Micelle Nanoparticles: Formation, Characterization, Tissue Distribution, Pharmacokinetics and Effects for Ischemic Stroke
por: Song, Weitong, et al.
Publicado: (2022)

Chemotherapy plus Panitumumab Versus Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-analysis
por: Li, Zhigui, et al.
Publicado: (2018)

Highly Resolved Phylogenetic Relationships within Order Acipenseriformes According to Novel Nuclear Markers
por: Luo, Dehuai, et al.
Publicado: (2019)

The Efficacy and Safety of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease
por: Tang, Hui, et al.
Publicado: (2021)

Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review
por: Li, Jiarui, et al.
Publicado: (2020)

Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy
por: Wu, Bin, et al.
Publicado: (2014)

microRNA‐222 promotes colorectal cancer cell migration and invasion by targeting MST3
por: Luo, Fei, et al.
Publicado: (2019)

Immunohistochemical detection of cancer-associated fibroblasts in gastrointestinal cancer as a potential prognostic biomarker of survival: meta-analysis
por: Gu, Junjie, et al.
Publicado: (2020)

Case report: Peritumoral hepatic steatosis in a patient with a metastatic somatostatin-producing oligosymptomatic neuroendocrine neoplasm
por: Shao, Yuming, et al.
Publicado: (2022)

Early assessment of circulating exosomal lncRNA-GC1 for monitoring neoadjuvant chemotherapy response in gastric cancer
por: Guo, Xin, et al.
Publicado: (2023)

Multi-Modality Treatment for Patients With Metastatic Gastric Cancer: A Real-World Study in China
por: Zhao, Lin, et al.
Publicado: (2019)

Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer
por: Ni, Chao, et al.
Publicado: (2020)

Current Trends in Chemotherapy in the Treatment of Metastatic Prostate Cancer
por: Zhao, Janice, et al.
Publicado: (2023)

Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer Patients With Different Metastatic Sites: A Systematic Review and Meta-Analysis
por: Yang, Kaili, et al.
Publicado: (2020)

Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy
por: Li, Yuyong, et al.
Publicado: (2018)

Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma
por: Wang, Dong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h41qurrbnrojv7nkbj85pfat0t